The Global Initiatives Supporting the Adoption of Biopharmaceuticals To Drive the Biopharmaceutical Processing Equipment and Consumables Market
Biopharmaceuticals are revolutionizing the treatment of a range of diseases and are being used across various branches of medicine. The adoption of biopharmaceuticals is rising compared to conventional synthetic drugs owing to advantages, such as targeting specific sites, lowering the incidences of side effects, and high activity & specificity. Further, biopharmaceuticals are also found to be suitable for the treatment of patients who inadequately respond to conventional synthetic drugs. At present, antibody-based biopharmaceuticals are dominating the market. Further, there is large number of antibody-based biopharmaceuticals present in the clinical pipeline of various biopharmaceutical companies. As per the data released by an international non-profit antibody-related research and development organization, the Antibody Society, as of January 10, 2021, nearly 21 investigational antibody therapeutics are under regulatory review in the U.S. and European Union. From January 1, 2...